Intravaginal submucosal injection of HPV DNA vaccine followed by electroporation generated significantly more infiltrating IFN-γ-secreting CD8 + T cells in the tumor tissue.

An intravaginal ring with combination estradiol and progesterone was safe and effective in treating vasomotor symptoms in postmenopausal women, according to phase 1/2 study results published in ...

A novel intravaginal ring implanted with anti-retroviral drug tablets, or pods, demonstrated sustained and controlled drug release and safety over 28 days, according to a study. The ring, designed ...

Conclusions: Intravaginal 10μg 17-β estradiol provided relief from menopausal symptoms and improvement in sexual dysfunction in the domains of lubrication, desire, satisfaction, orgasm, and pain. This ...

The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.

Intravaginal Practices, Bacterial Vaginosis, and HIV Infection in Women: Individual Participant Data Meta-analysis. PLoS Medicine, 2011; 8 (2): e1000416 DOI: 10.1371/journal.pmed.1000416 ...

A new intravaginal ring (IVR) has been developed for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a contraceptive ...

DARE-HRT1, an investigational ethylene vinyl acetate copolymer intravaginal ring (IVR) designed to release bio-identical 17β2-estradiol and progesterone over 28 days as part of a hormone therapy ...

Microbicides can act in various ways (Fig. 2). Microbicides can be nonspecific, moderately specific or highly (exclusively) specific to HIV (Box 1). The nonspecific and moderately specific agents are ...

Daré Bioscience, Inc. Thu, Apr 11, 2024, 8:00 AM11 min read ...